Rejuve Biotech Inc.

CIK 1994911 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Rejuve Biotech Inc..

Recent SEC filings

FiledFormAccession number
May 7, 2026C-AR0001994911-26-000005
Apr 30, 2025C-AR0001669191-25-000296
Feb 21, 2025C-U0001669191-25-000122
Sep 13, 2024C/A0001669191-24-000924
Jun 26, 2024C/A0001669191-24-000675
Apr 26, 2024C/A0001669191-24-000462
Mar 12, 2024C/A0001669191-24-000263
Feb 27, 2024C/A0001669191-24-000204
Feb 20, 2024C0001669191-24-000192